人工血管の世界市場

出版:BCC Research(BCCリサーチ) 出版年月:2023年11月

Global Market for Artificial Blood Vessels

人工血管の世界市場

ページ数68
図表数41
価格
種別英文調査報告書

お問合せ・ご注文  価格・納期について

Report Overview

The report provides an overview of the global market for artificial blood vessels and its related segment. The report has been segmented based on type, application, and geographical region. Using 2022 as the base year, the report provides estimated market data for 2023 through 2028. The report also provides information on emerging technologies, ESG developments, and mergers and acquisitions, and strategic initiatives by various companies.

人工血管の世界市場

Summary:

This report comprehensively analyzes the artificial blood vessels market, which is segmented based on type, application and region.

Segmentation based on type includes expanded polytetrafluoroethylene (ePTFE), polyethylene terephthalate (like Dacron), or polyurethane and others.

Segmentation based on application includes aortic disease, peripheral artery disease and hemodialysis.

The regional markets covered are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

This report provides a complete review and analysis of the current artificial blood vessels market and industry growth drivers and restraints. The report also focuses on emerging technologies, ESG developments and mergers and acquisitions by various players in the market.

Revenues are broken down by region, type and application. For market estimates, data has been provided for 2020, 2021, and 2022 as the base year, and a forecast for 2023 through 2028.

Report Scope:

The scope of this study encompasses an investigation of the global market for artificial blood vessels, focusing on various important aspects of the market, demand for the product, the current and future market potential for artificial blood vessels and a detailed analysis of the competitive landscape.

BCC Research analyzes each market segment and provides a forecast for five years. The current report analyzes the market’s drivers, challenges, and opportunities. The report also covers market projections through 2028 and the market share for key market players. The report includes the company profiles of key players with detailed information about their business segments, product portfolios, and recent developments. The report also provides information on emerging technologies, ESG developments, and mergers and acquisitions, and strategic initiatives by various companies.

Report Synopsis

Report MetricsDetails
Base year considered2022
Forecast period considered2023-2028
Base year market size$2.1 billion
Market size forecast$2.8 billion
Growth rateCAGR of 5.3% for the forecast period of 2023-2028
Units considered$ Millions
Segments coveredType, Application
Regions coveredNorth America, Europe, Asia-Pacific, Rest of the World (RoW)
Key Market DriversIncreasing Prevalence of Cardiovascular Diseases
Increasing Prevalence of Peripheral Artery Disease and End-Stage Renal Disease
Growing Geriatric Population and Changing Lifestyles
Strategic Initiatives
Companies studiedARTIVION INC.
B. BRAUN SE
BECTON, DICKINSON AND COMPANY
GETINGE AB.
HUMACYTE
LEMAITRE VASCULAR INC.
TERUMO CORP.
W. L. GORE & ASSOCIATES INC.

Report Includes:

  • An overview of the global market landscape related to the artificial blood vessels
  • In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
  • Evaluation of the current market size and revenue growth prospects specific to artificial blood vessels, accompanied by a comprehensive market share analysis categorized by type, application, and geographical region
  • Highlights of the current and future market potential and a detailed analysis of the regulatory framework and reimbursement scenarios
  • Information on tissue-engineered vascular grafts (TEVGs), their clinical applications, and vascular grafts currently in use; and description of common materials used for artificial blood vessels such as synthetic polymers, natural biomaterials and hybrid materials
  • Review of patents, product pipeline, ESG trends, and emerging technologies related to artificial blood vessels
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and a relevant patent analysis
  • Detailed profiles of leading market participants, providing a descriptive overview of their respective businesses

Table of Contents


Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown
Chapter 2 Summary and Highlights
Market Overview
Chapter 3 Market and Technology Background
Introduction
History
Vascular Grafts in Use
Synthetic Grafts
Autologous Blood Vessels
Cryopreserved Grafts
Xenografts
Common Materials for Artificial Blood Vessels
Synthetic Polymers
Natural Biomaterials
Hybrid Materials
Chapter 4 Market Dynamics
Market Drivers
Increasing Prevalence of Cardiovascular Diseases
Increasing Prevalence of Peripheral Artery Disease and End-Stage Renal Disease
Growing Geriatric Population and Changing Lifestyles
Strategic Initiatives
Market Restraints
Graft Failures
High Cost of Production and Regulatory Hurdles
Chapter 5 Market Breakdown by Type
Overview
Expanded Polytetrafluoroethylene (ePTFE)
Polyethylene Terephthalate (PET)
Polyurethane (PU)
Others
Chapter 6 Market Breakdown by Application
Overview
Aortic Diseases
Peripheral Artery Disease and Vascular Trauma
Hemodialysis
Chapter 7 Market Breakdown by Region
Overview
North America
Europe
Asia-Pacific
Rest of the World
Chapter 8 Sustainability: An ESG Perspective
Introduction
Environmental Factors
Social Factors
Governance Factors
Case Study
Conclusion
Chapter 9 Emerging Technologies and Developments
Introduction
Tissue-Engineered Vascular Grafts (TEVGs)
Clinical Applications of TEVG
Chapter 10 Competitive Landscape
Porter’s Five Forces Analysis
Threat of New Entrants
Threat of Substitutes
Bargaining Power of Suppliers
Bargaining Power of Buyers
Degree of Competition
Recent Developments in Artificial Blood Vessels Market
Competitive Analysis
Chapter 11 Company Profiles
ARTIVION INC.
B. BRAUN SE
BECTON, DICKINSON AND COMPANY
GETINGE AB.
HUMACYTE
LEMAITRE VASCULAR INC.
TERUMO CORP.
W. L. GORE & ASSOCIATES INC.

List of Tables
Table A : Global Market for Artificial Blood Vessels, Through 2028
Table B : Global Market for Artificial Blood Vessels, by Region, Through 2028
Table 1 : Advantages and Disadvantages of Artificial Blood Vessels in Different Materials
Table 2 : Estimated Deaths Due to Cardiovascular Disease, by Sex and Disease, 2019
Table 3 : Global Market for Artificial Blood Vessels, by Type, Through 2028
Table 4 : Global Market for Artificial Blood Vessels for Expanded Polytetrafluoroethylene, by Region, Through 2028
Table 5 : Global Market for Artificial Blood Vessels for Polyethylene Terephthalate, by Region, Through 2028
Table 6 : Global Market for Artificial Blood Vessels for Polyurethane, by Region, Through 2028
Table 7 : Global Market for Artificial Blood Vessels for Others, by Region, Through 2028
Table 8 : Global Market for Artificial Blood Vessels, by Application, Through 2028
Table 9 : Global Market for Artificial Blood Vessels for Aortic Diseases, by Region, Through 2028
Table 10 : Global Market for Artificial Blood Vessels for Peripheral Artery Disease and Vascular Trauma, by Region, Through 2028
Table 11 : Global Market for Artificial Blood Vessels for Hemodialysis, by Region, Through 2028
Table 12 : Global Market for Artificial Blood Vessels, by Region, Through 2028
Table 13 : Environmental Initiatives by Various Artificial Blood Vessel Companies
Table 14 : ESG Rankings for Companies in the Artificial Blood Vessels Market, 2023
Table 15 : Getinge Sustainability Analysis
Table 16 : TEVG Clinical Trials, 2023
Table 17 : Porter’s Five Force Analysis
Table 18 : Recent Developments in Artificial Blood Vessels, 2023
Table 19 : B. Braun SE: Marketed Products
Table 20 : Becton, Dickinson, and Company (BD): Marketed Products
Table 21 : Getinge AB: Marketed Products
Table 22 : LeMaitre Vascular: Marketed Products
Table 23 : Terumo Corp: Marketed Products
Table 24 : W. L. Gore & Associates Inc.: Marketed Products

List of Figures
Figure A : Global Market for Artificial Blood Vessels, 2020-2028
Figure B : Global Market for Artificial Blood Vessels, by Region, 2020-2028
Figure 1 : Generation of Artificial Blood Vessels
Figure 2 : Vascular Grafts: Strengths and Weaknesses
Figure 3 : Global Market for Artificial Blood Vessels, by Type, 2020-2028
Figure 4 : Global Market Shares of Artificial Blood Vessels, by Type, 2022
Figure 5 : Global Market for Artificial Blood Vessels for Expanded Polytetrafluoroethylene, by Region, 2020-2028
Figure 6 : Global Market for Artificial Blood Vessels for Polyethylene Terephthalate, by Region, 2020-2028
Figure 7 : Global Market for Artificial Blood Vessels for Polyurethane, by Region, 2020-2028
Figure 8 : Global Market for Artificial Blood Vessels for Others, by Region, 2020-2028
Figure 9 : Global Market for Artificial Blood Vessels, by Application, 2020-2028
Figure 10 : Global Market Shares of Artificial Blood Vessels, by Application, 2022
Figure 11 : Global Market for Artificial Blood Vessels for Aortic Diseases, by Region, 2020-2028
Figure 12 : Global Market for Artificial Blood Vessels for Peripheral Artery Disease and Vascular Trauma, by Region, 2020-2028
Figure 13 : Global Market for Artificial Blood Vessels for Hemodialysis, by Region, 2020-2028
Figure 14 : Global Market for Artificial Blood Vessels, by Region, 2020-2028
Figure 15 : Global Market Shares of Artificial Blood Vessels, by Region, 2022
Figure 16 : Key Factors for Ideal Vascular Graft
Figure 17 : Global Market Shares of Artificial Blood Vessels, by Companies, 2022